Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

RTOG-0421 QP: Radiation Therapy Oncology Group Performance Status Scale Miscellaneous Patient Assessment Form NCT00113399

- 21/06/2015 - 1 Formulário, 3 Grupos de itens, 22 Elementos de dados, 1 Idioma

Grupos de itens: RTOG clinical trial administrative data, Miscellaneous Patient Assessment, COMMENTS

RTOG-0421 QP: Radiation Therapy Oncology Group Performance Status Scale Miscellaneous Patient Assessment Form NCT00113399 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EB3722D1-7299-70BB-E034-0003BA3F9857

RTOG-0522 FA: FACT (Function Assessment Cancer Therapy) NCT00265941

- 21/06/2015 - 1 Formulário, 6 Grupos de itens, 49 Elementos de dados, 1 Idioma

Grupos de itens: RTOG clinical trial administrative data, PHYSICAL WELL-BEING, SOCIAL/FAMILY WELL-BEING, EMOTIONAL WELL-BEING, FUNCTIONAL WELL-BEING, ADDITIONAL CONCERNS

RTOG-0522 FA: FACT (Function Assessment Cancer Therapy) NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F60B771F-164B-2C87-E034-0003BA3F9857

RTOG-0421 I6: Radiation Therapy Oncology Group Phase III Recurrent Head and Neck Study Staging Diagrams / Hypopharynx NCT00113399

- 21/06/2015 - 1 Formulário, 2 Grupos de itens, 13 Elementos de dados, 1 Idioma

Grupos de itens: RTOG clinical trial administrative data, Head and Neck Tumor

RTOG-0421 I6: Radiation Therapy Oncology Group Phase III Recurrent Head and Neck Study Staging Diagrams / Hypopharynx NCT00113399 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EB3979F3-3B1D-2588-E034-0003BA3F9857

RTOG-0421 I6: Radiation Therapy Oncology Group Phase III Recurrent Head and Neck Study Staging Diagrams / Larynx NCT00113399

- 21/06/2015 - 1 Formulário, 2 Grupos de itens, 12 Elementos de dados, 1 Idioma

Grupos de itens: RTOG clinical trial administrative data, Larynx Tumor

RTOG-0421 I6: Radiation Therapy Oncology Group Phase III Recurrent Head and Neck Study Staging Diagrams / Larynx NCT00113399 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EB4905D5-B71C-6C3A-E034-0003BA3F9857

RTOG-0522 I7: Radiation Therapy Oncology Group Phase III Head and Neck Study Dosimetry Nodal Planning Diagram NCT00265941

- 21/06/2015 - 1 Formulário, 2 Grupos de itens, 13 Elementos de dados, 1 Idioma

Grupos de itens: RTOG clinical trial administrative data, Head and Neck Lymph node

RTOG-0522 I7: Radiation Therapy Oncology Group Phase III Head and Neck Study Dosimetry Nodal Planning Diagram NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F6217E11-C792-5543-E034-0003BA3F9857

E1305 Treatment Form NCT00588770

- 16/06/2015 - 1 Formulário, 11 Grupos de itens, 37 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Arm A and Arm B, Vital Status, Agent Name: Cisplatin, Agent Name: Carboplatin, Agent Name: Docetaxel, Agent Name: 5-FU, Agent Name: Bevacizumab, Non-Protocol Therapy, Footer Module

E1305 Treatment Form NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=19F79B13-026F-5DCC-E044-0003BA3F9857

E1305 Source Document Tracking Coversheet NCT00588770

- 16/06/2015 - 1 Formulário, 3 Grupos de itens, 14 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Footer module

E1305 Source Document Tracking Coversheet NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=19F77651-8901-3675-E044-0003BA3F9857

ECOG Second Primary Form NCT00588770

- 16/06/2015 - 1 Formulário, 4 Grupos de itens, 19 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Second primary cancer assessment, Comments

ECOG Second Primary Form NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17220911-5226-6039-E044-0003BA3F9857

ECOG Non-Protocol Therapy Form NCT00588770

- 16/06/2015 - 1 Formulário, 4 Grupos de itens, 25 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Off-protocol treatment, Comments

ECOG Non-Protocol Therapy Form NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1A08BE26-4EC6-3573-E044-0003BA3F9857

RTOG-0421 TF: Radiation Therapy Oncology Group Phase III Recurrent Head and Neck Study Treatment Summary Form NCT00113399

- 12/06/2015 - 1 Formulário, 4 Grupos de itens, 23 Elementos de dados, 1 Idioma

Grupos de itens: RTOG clinical trial administrative data, Assessment of chemotherapy, Comments, Comments

RTOG-0421 TF: Radiation Therapy Oncology Group Phase III Recurrent Head and Neck Study Treatment Summary Form NCT00113399 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EC64FA04-6994-6A06-E034-0003BA3F9857

E1305 Nontarget Lesions Supplemental Form (RECIST) NCT00588770

- 08/06/2015 - 1 Formulário, 6 Grupos de itens, 24 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Data amendment, ON TREATMENT, OFF TREATMENT, NONTARGET LESIONS, Comments

E1305 Nontarget Lesions Supplemental Form (RECIST) NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=19F717BA-DF10-2BA5-E044-0003BA3F9857

E1305 Follow-Up Disease Evaluation Form (RECIST) NCT00588770

- 08/06/2015 - 1 Formulário, 11 Grupos de itens, 32 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Data amendment, ON TREATMENT, OFF TREATMENT, Disease assessment, TARGET LESIONS, NONTARGET LESIONS, New Lesions, Overall Response per RECIST Criteria - Target, Nontarget and New Lesions, Symptomatic Deterioration, Comments

E1305 Follow-Up Disease Evaluation Form (RECIST) NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=19FAD740-2B45-48C6-E044-0003BA3F9857

Palavras-chave

Índice

Modelos de dados selecionados